ASD II, Percutaneous Closure, Zero-fluoroscopy
Conditions
Brief summary
Background: An atrial septal defect (ASD) is considered oval-shaped when its shortest diameter is less than 75% of its longest diameter. Research on the percutaneous closure of oval-shaped ASDs is limited, and to our knowledge, there are no reports of non-fluoroscopic closure for this specific population. Objective: To assess the effectiveness of non-fluoroscopic percutaneous closure for oval-shaped ASDs. Methods: This single-center, retrospective study examines patients undergoing percutaneous closure of oval-shaped ASDs using a non-fluoroscopy technique for initial decision-making. The device was selected to be approximately 0-4 mm larger than the longest diameter of the defect, based on measurements from transthoracic and transesophageal ultrasound.
Detailed description
Background: An atrial septal defect (ASD) is considered oval-shaped when its shortest diameter is less than 75% of its longest diameter. Research on the percutaneous closure of oval-shaped ASDs is limited, and to our knowledge, there are no reports of non-fluoroscopic closure for this specific population. Objective: To assess the effectiveness of non-fluoroscopic percutaneous closure for oval-shaped ASDs. Methods: This single-center, retrospective study examines patients undergoing percutaneous closure of oval-shaped ASDs using a non-fluoroscopy technique for initial decision-making. The device was selected to be approximately 0-4 mm larger than the longest diameter of the defect, based on measurements from transthoracic and transesophageal ultrasound.
Interventions
DEVICEZero-fluoroscopy ASD closure
Percutaneous ASD closure without fluoroscopy was performed in secundum-type oval-shaped ASD
Sponsors
National Cardiovascular Center Harapan Kita Hospital Indonesia
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Intervention model description
Zero-fluoroscopy oval-shaped secundum ASD closure
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* Oval-shaped secundum ASD with evidence of right ventricular overload, no significant and irreversible pulmonary arterial hypertension, no significant arrhythmia, no serious problems in other organs, and presumption of appropriate rims for device implantation
Exclusion criteria
* Other than stated in inclusion criteria
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Success rate | five years |
Countries
Indonesia
Outcome results
None listed